View Post

A novel strategy to potentially reduce breast cancer bone metastasis

In In The News by Barbara Jacoby

Source: Baylor College of Medicine From: eurekalert.org Uncovering a novel mechanism that promotes growth of breast cancer bone metastasis has revealed a potential Achilles’ heel for these cancer cells. Reported in the journal Cancer Cell, the study shows that interfering with this mechanism can reduce the risk of relapses in animal models. “Metastasis is the dissemination of cancer cells from …

View Post

Whisking Away Cancer with a Wiry Tool

In In The News by Barbara Jacoby

By: Karin McCay From: kcbd.com If you like to cook, you probably have a whisk in your kitchen. Mine cost about 4 dollars. Surgeons are using something that looks a lot like a whisk, except it costs about 4 thousand dollars. A lot of women with breast cancer will tell you it is worth every penny. I met two of …

View Post

New Study Cements Fact That Mammography is a Primary Factor in Reduced Breast Cancer Deaths

In In The News by Barbara Jacoby

Source: American College of Radiology Via: prnewswire.com Tabar et al — published online November 8 in Cancer — debunks claims that mammography screening is not a primary factor in plummeting breast cancer deaths and reinforces the long-proven fact that Mammography Saves Lives™. The study showed that women screened regularly for breast cancer have a 47 percent lower risk of dying …

View Post

Is New BRCA Breast Cancer Drug Worth the Price?

In In The News by Barbara Jacoby

From: healthline.com The first drug approved to treat BRCA-related breast cancer has limits, but it’s important for women with metastatic disease and BRCA mutation carriers There’s a new drug to treat one of the tougher types of breast cancer. It’ll buy you about three extra months of what’s called progression-free survival. And it’ll cost you, or your insurance company, $13,000 …

View Post

Genetic “whodunnit” for cancer gene solved

In In The News by Barbara Jacoby

From: Salk Institute for Biological Studies Salk scientists find how the enzyme AMPK, largely thought to suppress cancer, actually helps some tumors survive Long thought to suppress cancer by slowing cellular metabolism, the protein complex AMPK also seemed to help some tumors grow, confounding researchers. Now, Salk Institute researchers have solved the long-standing mystery around why AMPK can both hinder …

View Post

3 ways physician-pharma partnerships are improving quality of care

In In The News by Barbara Jacoby

By: Jack Pinney, MD From: kevinmd.com We’ve all heard about the importance of greater stakeholder collaboration in health care. It’s the premise of current movements aimed at improving the outlook on some of the most costly, chronic conditions. Like most physicians today, I maintain a tight work schedule to keep bottom-line margins in the black. On a daily basis, I …

View Post

FREE Immunotherapy Patient Summit – Houston, Sat, December 8, 2018

In In The News by Barbara Jacoby

From: CANCER RESEARCH INSTITUTE Date and Time:  Sat, December 8, 2018 – 10:00 AM – 3:30 PM PDT Hosted at MD Anderson Cancer Center Dan L. Duncan Cancer Prevention Building, (CPB) – 8th Floor Conference Center 1155 Pressler Street Houston, TX 77030 Learn about the basics of cancer immunotherapy, a highly promising new approach to cancer treatment. Medical experts along with …

View Post

Savvy crowned one of Most Daring Entrepreneurs by Entrepreneur magazine!

In In The News by Barbara Jacoby

Extra! Extra! FROM OUR FRIENDS AT SAVVY COOPERATIVE! We have really exciting news, hot off the press today! Entrepreneur magazine has just named Savvy founder, Jen Horonjeff, one of the Most Daring Entrepreneurs of 2018! The list includes other notable CEOs, founders and creators – from Elon Musk and Arlan Hamilton, to Chance the Rapper and Reese Witherspoon. The recognition is part …

View Post

New virus could help destroy cancer

In In The News by Barbara Jacoby

By: Chiara Townley From: medicalnewstoday.com A new study examines the behavior of a cancer-killing virus that fits tumor cells perfectly and leaves healthy cells intact. Cancer is a chronic disease that kills millions of people worldwide. According to the World Health Organization (WHO), cancer is the second leading cause of death globally and is likely to be responsible for more …

View Post

Approval in 2 Weeks via FDA’s New Oncology Drugs Review

In In The News by Barbara Jacoby

By: Zosia Chustecka From: medscape.com One of the first new approvals to emerge from the US Food and Drug Administration’s (FDA’s) new process for reviewing oncology drugs took only 2 weeks from submission of the supplemental application to approval for the new indication. The approval was for expanded use of brentuximab vedotin (Adcetris, Seattle Genetics). The drug can now be …